Trial intelligence / Profile preview

Isotretinoin Effects in Women With Acne and PCOS

NCT02855138Phase 4Completed

Sponsor
Kayseri Education and Research Hospital
Start
Jan 2015
Primary completion
Mar 2016
Modality
Small Molecules
01

Overview

Phase 4, open-label trial of isotretinoin in acne vulgaris (2 arms), sponsored by Kayseri Education and Research Hospital. Primary endpoint: Adverse Events on the Gonads and Hirsutism That are Related to Treatment at 6 months. Started Jan 2015; status: completed.

02

Drugs

isotretinoin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT02855138.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02855138.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call